P4Q-13627-43460
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 993 / WA
- Registered
- 2022-07-05
- Relationship
- Child or adolescent in my care
- Guardian
- G9N-88249-36374
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-02
Dose 1 — Moderna
-
2022-07-05
Registered in v-safe
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-09
- 2022-07-16
- 2022-07-23
- 2022-08-03
- 2022-08-06
- 2022-08-13
-
2022-09-04
Dose 2 — Moderna
- 2022-09-05
- 2022-09-06
- 2022-09-07
- 2022-09-08
-
2022-09-09
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-09-10
- 2022-09-11
-
2022-09-18
Survey response — day 14, dose 2, under 3MedDRA: Irritability, Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: FairFree text: Cold-like symptoms - stuffy, fussy. Covid tests negativeMedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-12-04
- 2023-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-02 | Moderna | No |
| 2 | 2022-09-04 | Moderna | No |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Cold-like symptoms - stuffy, fussy. Covid tests negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release